Clinical and laboratory factors associated with the severity of proliferative sickle cell retinopathy in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease

Medicine

Volumn 90, Issue 6, 2011, Pages 372-378

  Leveziel, Nicolas ^a   Bastuji Garin, Sylvie ^b,c   Lalloum, Franck ^a   Querques, Giuseppe ^a   Benlian, Pascale ^d   Binaghi, Michel ^a   Coscas, Gabriel ^a   Soubrane, Gisèle ^a   Bachir, Dora ^b   Galactéros, Frédéric ^b   Souied, Eric H ^a  

^a Department of Ophthalmology   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; HEMOGLOBIN F; IRON;

ACUTE CHEST SYNDROME; ACUTE PYELONEPHRITIS; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BONE NECROSIS; CHILD; CHOLECYSTECTOMY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIZZINESS; EYE EXAMINATION; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GOLDBERG CLASSIFICATION; HEARING IMPAIRMENT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN SC DISEASE; HUMAN; INFECTION; IRON BLOOD LEVEL; LUNG ARTERY PRESSURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; OSTEOMYELITIS; PRIORITY JOURNAL; PROLIFERATIVE SICKLE CELL RETINOPATHY; PULMONARY HYPERTENSION; RETINOPATHY; SCHOOL CHILD; SEX DIFFERENCE; SICKLE CELL ANEMIA; STROKE; THROMBOPHLEBITIS; TINNITUS;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEMOGLOBIN SC DISEASE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETINAL DISEASES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80755135501     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e3182364cba     Document Type: Article

References (24)

1. Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, James AH, Laraque D, Mendez M, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008;148:932-938. (Pubitemid 351860825)
2. Clarkson JG. The ocular manifestations of sickle-cell disease: a prevalence and natural history study. Trans Am Ophthalmol Soc. 1992;90:481-504. (Pubitemid 23048910)
3. Diallo JW, Sanfo O, Blot I, Meda N, Sawadogo P, Ouedraogo A, Simpore J. EEpidemiology and prognostic factors for sickle cell retinopathy in Ouagadougou (Burkina Faso). J Fr Ophtalmol. 2009;32:496-500.
4. Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant GR, Bird AC. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology. 2005;112:1869-1875. (Pubitemid 41551912)
5. El-Hazmi MA, Warsy AS, Addar MH, Babae Z. Fetal haemoglobin levelVeffect of gender, age and haemoglobin disorders. Mol Cell Biochem. 1994;135:181-186. (Pubitemid 24307929)
6. Fadugbagbe AO, Gurgel RQ, Mendonca CQ, Cipolotti R, dos Santos AM, Cuevas LE. Ocular manifestations of sickle cell disease. Ann Trop Paediatr. 2010;30:19-26.
7. Fox PD, Dunn DT, Morris JS, Serjeant GR. Risk factors for proliferative sickle retinopathy. Br J Ophthalmol. 1990;74:172-176. (Pubitemid 20106092)
8. Gill HS, Lam WC. A screening strategy for the detection of sickle cell retinopathy in pediatric patients. Can J Ophthalmol. 2008;43:188-191. (Pubitemid 351518170)
9. Gladwin M, Sachdev V, Jison M, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:22-31.
10. Goldberg MF. Natural history of untreated proliferative sickle retinopathy. Arch Ophthalmol. 1971;85:428-437.
11. Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modeling strategies for improved prognostic prediction. Stat Med. 1984;3:143-152. (Pubitemid 14052973)
12. Herman EC, Conley CL. Hereditary persistence of fetal hemoglobin. A family study. Am J Med. 1960;29:9-17.
13. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley & Sons; 1989.
14. Hotaling AJ, Hillstrom RP, Bazell C. Sickle cell crisis and sensorineural hearing loss: case report and discussion. Int J Pediatr Otorhinolaryngol. 1989;17:207-211. (Pubitemid 19197539)
15. Joannes MO, Loko G, Deloumeaux J, Chout R, Marianne-Pepin T. Association of the +874 T/A interferon gamma polymorphism with infections in sickle cell disease. Int J Immunogenet. 2010;37:219-223.
16. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21:37-47. (Pubitemid 46110926)
17. Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest. 1984;74:652-656. (Pubitemid 14054015)
18. Roberts I, de Montalembert M. Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe Editorial. Haematologica. 2007;92:865-871. (Pubitemid 350144231)
19. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653-1662. (Pubitemid 40471796)
20. Schechter AN, Rodgers GP. Hydroxyurea in sickle cell disease EComment. N Engl J Med. 1996;334:333.
21. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 2000;407:538-541.
22. Solovey A, Kollander R, Milbauer LC, Abdulla F, Chen Y, Kelm RJ Jr, Hebbel RP. Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse. Am J Hematol. 2010;85:41-45.
23. Steinberg MH, Hsu H, Nagel RL, Milner PF, Adams JG, Benjamin L, Fryd S, Gillette P, Gilman J, Josifovska O, Hellman-Erlingsson S, Safaya S, Huey L, Rieder RF. Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am J Hematol. 1995;48:175-181.
24. Talbot JF, Bird AC, Maude GH, Acheson RW, Moriarty BJ, Serjeant GR. Sickle cell retinopathy in Jamaican children: further observations from a cohort study. Br J Ophthalmol. 1988;72:727-732.